Literature DB >> 5703957

Serum monoamine oxidase (MAO) in diabetes mellitus and some other internal diseases.

S E Nilsson, N Tryding, G Tufvesson.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1968        PMID: 5703957     DOI: 10.1111/j.0954-6820.1968.tb02429.x

Source DB:  PubMed          Journal:  Acta Med Scand        ISSN: 0001-6101


× No keyword cloud information.
  5 in total

1.  Involvement of semicarbazide-sensitive amine oxidase-mediated deamination in lipopolysaccharide-induced pulmonary inflammation.

Authors:  Peter H Yu; Li-Xin Lu; Hui Fan; Mychaylo Kazachkov; Zhong-Jian Jiang; Sirpa Jalkanen; Craig Stolen
Journal:  Am J Pathol       Date:  2006-03       Impact factor: 4.307

2.  Aminoguanidine inhibits semicarbazide-sensitive amine oxidase activity: implications for advanced glycation and diabetic complications.

Authors:  P H Yu; D M Zuo
Journal:  Diabetologia       Date:  1997-11       Impact factor: 10.122

3.  Increase of formation of methylamine and formaldehyde in vivo after administration of nicotine and the potential cytotoxicity.

Authors:  P H Yu
Journal:  Neurochem Res       Date:  1998-09       Impact factor: 3.996

4.  Overexpression of semicarbazide-sensitive amine oxidase in smooth muscle cells leads to an abnormal structure of the aortic elastic laminas.

Authors:  Camilla Göktürk; Joakim Nilsson; Jenny Nordquist; Millvej Kristensson; Kristian Svensson; Charlotte Söderberg; Marianne Israelson; Håkan Garpenstrand; Mats Sjöquist; Lars Oreland; Karin Forsberg-Nilsson
Journal:  Am J Pathol       Date:  2003-11       Impact factor: 4.307

5.  [Monoamine oxidase activity in brain regions and organs of patients with Parkinson's disease and Huntington's disease and serum MAO activity of patients with Huntington's disease as compared with neurologically healthy individuals (author's transl)].

Authors:  G Schneider; H Oepen; H R von Wedel
Journal:  Arch Psychiatr Nervenkr (1970)       Date:  1981
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.